| |
| |
|
| Insider
Information: |
Schneider Eugene |
| Relationship: |
EVP, Chf Clinical Deve... |
| City: |
Carlsbad, |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
49,812 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,038,805 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
49,812 |
|
|
| Total
Value |
$2,038,805 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ionis Pharmaceuticals Inc |
IONS |
EVP, Chf Clinical Deve... |
2024-02-02 |
49,812 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
22 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chf Clinical Develop Ofcr |
• – – |
2024-02-02 |
4 |
S |
$49.59 |
$102,701 |
D/D |
(2,071) |
49,812 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chf Clinical Develop Ofcr |
• – – |
2024-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,033 |
51,883 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chf Clinical Develop Ofcr |
• – – |
2024-01-17 |
4 |
S |
$50.42 |
$276,386 |
D/D |
(5,482) |
47,850 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chf Clinical Develop Ofcr |
• – – |
2024-01-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,162 |
53,332 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chf Clinical Develop Ofcr |
• – – |
2024-01-12 |
4 |
OE |
$32.60 |
$260,800 |
D/D |
8,000 |
46,170 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chf Clinical Develop Ofcr |
• – – |
2024-01-12 |
4 |
S |
$53.50 |
$427,999 |
D/D |
(8,000) |
38,170 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chf Clinical Develop Ofcr |
• – – |
2023-12-26 |
4 |
S |
$51.46 |
$1,286,575 |
D/D |
(25,000) |
36,052 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chf Clinical Develop Ofcr |
• – – |
2023-12-26 |
4 |
OE |
$47.34 |
$1,183,500 |
D/D |
25,000 |
61,052 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chf Clinical Develop Ofcr |
• – – |
2023-02-06 |
4 |
S |
$40.67 |
$57,464 |
D/D |
(1,413) |
24,946 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chf Clinical Develop Ofcr |
• – – |
2023-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
4,033 |
26,359 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chf Clinical Develop Ofcr |
• – – |
2023-01-18 |
4 |
S |
$39.57 |
$188,052 |
D/D |
(4,752) |
22,326 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chf Clinical Develop Ofcr |
• – – |
2023-01-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,046 |
27,078 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chf Clinical Develop Ofcr |
• – – |
2022-10-17 |
4 |
D |
$46.52 |
$6,699 |
D/D |
(144) |
14,032 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chf Clinical Develop Ofcr |
• – – |
2022-10-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
416 |
14,176 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chf Clinical Develop Offc |
• – – |
2022-01-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,400 |
17,575 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chf Clinical Develop Offc |
• – – |
2022-01-18 |
4 |
D |
$30.12 |
$114,908 |
D/D |
(3,815) |
13,760 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chf Clinical Develop Offc |
• – – |
2021-10-15 |
4 |
D |
$35.10 |
$5,090 |
D/D |
(145) |
7,175 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chf Clinical Develop Offc |
• – – |
2021-10-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
417 |
7,320 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chf Clinical Develop Offc |
• – – |
2021-01-15 |
4 |
D |
$61.28 |
$166,559 |
D/D |
(2,718) |
6,903 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chf Clinical Develop Offc |
• – – |
2021-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,503 |
9,621 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chf Clinical Develop Ofcr |
• – – |
2020-12-27 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
13,224 |
|
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chf Clinical Develop Offc |
• – – |
2020-12-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,118 |
|
% |
|
22 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
